Cargando…
Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative
AIMS: Telemedicine is advocated as a fundamental tool in modern clinical management. However, data on the effects of telemedicine vs face-to-face consultation on clinical outcomes in type 2 diabetes (T2DM) are still uncertain. This paper describes the use of telemedicine during the 2020 COVID-19 eme...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663380/ https://www.ncbi.nlm.nih.gov/pubmed/36400169 http://dx.doi.org/10.1016/j.diabres.2022.110158 |
_version_ | 1784830861980467200 |
---|---|
author | Russo, Giuseppina T. Andreozzi, Francesco Calabrese, Mariella Di Bartolo, Paolo Di Cianni, Graziano Bruno Giorda, Carlo Lapice, Emanuela Manicardi, Elisa Giandalia, Annalisa Lucisano, Giuseppe Nicolucci, Antonio Rocca, Alberto Rossi, Maria Chiara Spreafico, Emanuele Vespasiani, Giacomo Manicardi, Valeria |
author_facet | Russo, Giuseppina T. Andreozzi, Francesco Calabrese, Mariella Di Bartolo, Paolo Di Cianni, Graziano Bruno Giorda, Carlo Lapice, Emanuela Manicardi, Elisa Giandalia, Annalisa Lucisano, Giuseppe Nicolucci, Antonio Rocca, Alberto Rossi, Maria Chiara Spreafico, Emanuele Vespasiani, Giacomo Manicardi, Valeria |
author_sort | Russo, Giuseppina T. |
collection | PubMed |
description | AIMS: Telemedicine is advocated as a fundamental tool in modern clinical management. However, data on the effects of telemedicine vs face-to-face consultation on clinical outcomes in type 2 diabetes (T2DM) are still uncertain. This paper describes the use of telemedicine during the 2020 COVID-19 emergency and compares volume activity and quality indicators of diabetes care between face-to-face vs telemedicine counseling in the large cohort of T2DM patients from the AMD Annals Initiative. METHODS: Demographic and clinical characteristics, including laboratory parameters, rate of the screening of long-term complications, current therapies and the Q-score, a validated score that measures the overall quality of care, were compared between 364,898 patients attending face-to-face consultation and 46,424 on telemedicine, during the COVID-19 pandemic. RESULTS: Patients on telemedicine showed lower HbA1c levels (7.1 ± 1.2 % vs 7.3 ± 1.3 %, p < 0.0001), and they were less frequently treated with metformin, GLP1-RAs and SGLT2i and more frequently with DPP4i. The telemedicine group showed reduced monitoring of the various parameters considered as process indicators, especially, eye and foot examination. The proportion of patients with a good quality of care (Q score > 25) was higher among those receiving face-to-face consultation. Moreover, in the telemedicine group, all major clinical outcomes remained stable when further compared to those collected in the year 2019, when the same patients underwent a regular face-to-face consultation, suggesting that the care provided through telemedicine did not negatively affect the most important parameters. CONCLUSIONS: During the COVID-19 pandemic, telemedicine provided an acceptable quality of diabetes care, comparable to that of patients attending face-to-face consultation, although a less frequent screening of complications seems to have occurred in subjects consulted by telemedicine. |
format | Online Article Text |
id | pubmed-9663380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96633802022-11-14 Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative Russo, Giuseppina T. Andreozzi, Francesco Calabrese, Mariella Di Bartolo, Paolo Di Cianni, Graziano Bruno Giorda, Carlo Lapice, Emanuela Manicardi, Elisa Giandalia, Annalisa Lucisano, Giuseppe Nicolucci, Antonio Rocca, Alberto Rossi, Maria Chiara Spreafico, Emanuele Vespasiani, Giacomo Manicardi, Valeria Diabetes Res Clin Pract Article AIMS: Telemedicine is advocated as a fundamental tool in modern clinical management. However, data on the effects of telemedicine vs face-to-face consultation on clinical outcomes in type 2 diabetes (T2DM) are still uncertain. This paper describes the use of telemedicine during the 2020 COVID-19 emergency and compares volume activity and quality indicators of diabetes care between face-to-face vs telemedicine counseling in the large cohort of T2DM patients from the AMD Annals Initiative. METHODS: Demographic and clinical characteristics, including laboratory parameters, rate of the screening of long-term complications, current therapies and the Q-score, a validated score that measures the overall quality of care, were compared between 364,898 patients attending face-to-face consultation and 46,424 on telemedicine, during the COVID-19 pandemic. RESULTS: Patients on telemedicine showed lower HbA1c levels (7.1 ± 1.2 % vs 7.3 ± 1.3 %, p < 0.0001), and they were less frequently treated with metformin, GLP1-RAs and SGLT2i and more frequently with DPP4i. The telemedicine group showed reduced monitoring of the various parameters considered as process indicators, especially, eye and foot examination. The proportion of patients with a good quality of care (Q score > 25) was higher among those receiving face-to-face consultation. Moreover, in the telemedicine group, all major clinical outcomes remained stable when further compared to those collected in the year 2019, when the same patients underwent a regular face-to-face consultation, suggesting that the care provided through telemedicine did not negatively affect the most important parameters. CONCLUSIONS: During the COVID-19 pandemic, telemedicine provided an acceptable quality of diabetes care, comparable to that of patients attending face-to-face consultation, although a less frequent screening of complications seems to have occurred in subjects consulted by telemedicine. The Authors. Published by Elsevier B.V. 2022-12 2022-11-15 /pmc/articles/PMC9663380/ /pubmed/36400169 http://dx.doi.org/10.1016/j.diabres.2022.110158 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Russo, Giuseppina T. Andreozzi, Francesco Calabrese, Mariella Di Bartolo, Paolo Di Cianni, Graziano Bruno Giorda, Carlo Lapice, Emanuela Manicardi, Elisa Giandalia, Annalisa Lucisano, Giuseppe Nicolucci, Antonio Rocca, Alberto Rossi, Maria Chiara Spreafico, Emanuele Vespasiani, Giacomo Manicardi, Valeria Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative |
title | Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative |
title_full | Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative |
title_fullStr | Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative |
title_full_unstemmed | Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative |
title_short | Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative |
title_sort | role of telemedicine during covid-19 pandemic in type 2 diabetes outpatients: the amd annals initiative |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663380/ https://www.ncbi.nlm.nih.gov/pubmed/36400169 http://dx.doi.org/10.1016/j.diabres.2022.110158 |
work_keys_str_mv | AT russogiuseppinat roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT andreozzifrancesco roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT calabresemariella roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT dibartolopaolo roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT diciannigraziano roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT brunogiordacarlo roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT lapiceemanuela roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT manicardielisa roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT giandaliaannalisa roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT lucisanogiuseppe roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT nicolucciantonio roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT roccaalberto roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT rossimariachiara roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT spreaficoemanuele roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT vespasianigiacomo roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT manicardivaleria roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative AT roleoftelemedicineduringcovid19pandemicintype2diabetesoutpatientstheamdannalsinitiative |